Stockholders' Deficiency- Warrants outstanding (Details) - shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Stockholders' Deficiency | |||
| Warrants outstanding | 10,200,004 | 10,400,008 | |
| Serious Seeds | |||
| Stockholders' Deficiency | |||
| Warrants outstanding | 200,004 | ||
| Remaining contractual life term | 0 years | ||
| Minimum | Serious Seeds | |||
| Stockholders' Deficiency | |||
| Remaining contractual life term | 0 years | 3 days | |
| Maximum | Serious Seeds | |||
| Stockholders' Deficiency | |||
| Remaining contractual life term | 11 months 4 days | ||
| CL Investors Inc | |||
| Stockholders' Deficiency | |||
| Warrants outstanding | 10,000,000 | ||
| Remaining contractual life term | 7 months 13 days | ||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|